Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 80255 BALTIMORE, MD
Back to TSHA Full portfolio

Position in TSHA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,358,554
+$648,030 QoQ
Shares Held
199,494
+25.5% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#85
of 208 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. TSHA ranks #164 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 2,678,047 $2,484,611,664
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,529,709 $953,834,749
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,728,421 $858,558,562
4 KYMR
Kymera Therapeutics, Inc.
 7,112,980 $815,645,416
5 RPRX
Royalty Pharma plc
 11,193,657 $627,628,347
6 RVMD
Revolution Medicines, Inc.
 2,969,853 $447,655,945
7 MRNA
Moderna, Inc.
 5,589,560 $391,436,886
8 TWST
Twist Bioscience Corp
 3,634,652 $373,932,997

All Filings in TSHA

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,358,554 199,494
2026-03-31 $710,524 158,954
2025-12-31 $669,977 121,814
2025-09-30 $372,240 113,835
2025-06-30 $195,432 84,603
2025-03-31 $102,894 74,025
2024-12-31 $113,022 65,331
2024-09-30 $120,035 59,719
2024-06-30 $2,859,533 1,276,578
2024-03-31 $3,155,074 1,099,329
2023-12-31 $2,172,379 1,227,333
2023-09-30 $3,942,008 1,247,471